Skip to main content

Advertisement

Log in

Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347:738–748

    Article  PubMed  CAS  Google Scholar 

  2. Montenegro V, Monteiro RC (1999) Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. Curr Opin Rheumatol 11:265–272

    Article  PubMed  CAS  Google Scholar 

  3. Veys EM, van Laere M (1973) Serum IgG, IgM and IgA levels in ankylosing spondylitis. Ann Rheum Dis 32:493–496

    Article  PubMed  CAS  Google Scholar 

  4. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ (1998) Patterns of cytokine production in psoriatic synovium. J Rheumatol 25:1544–1552

    PubMed  CAS  Google Scholar 

  5. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD (1994) Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 96:146–151

    Article  PubMed  CAS  Google Scholar 

  6. Lim CS, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S et al (2003) Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy. Nephrology 8:21–27

    Article  PubMed  CAS  Google Scholar 

  7. Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN (2005) Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int 67:602–612

    Article  PubMed  CAS  Google Scholar 

  8. Leung JC, Tang SC, Chan LY, Tsang AW, Lan HY, Lai KN (2003) Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 18:36–45

    Article  PubMed  CAS  Google Scholar 

  9. Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel NM et al (2000) Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57:499–509

    Article  PubMed  CAS  Google Scholar 

  10. Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E (2003) Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 14:1578–1583

    Article  PubMed  CAS  Google Scholar 

  11. Forshaw MJ, Guirguis O, Hennigan TW (2005) IgA nephropathy in association with Crohn’s disease. Int J Colorectal Dis 20:463–465

    Article  PubMed  CAS  Google Scholar 

  12. de Moura CG, de Moura TG, de Souza SP, Testagrossa L (2006) Inflammatory bowel disease, ankylosing spondylitis, and IgA nephropathy. J Clin Rheumatol 12:106–107

    Article  PubMed  Google Scholar 

  13. Yamamoto M, Yorioka T, Kawada M, Nishimura K, Kumon Y, Yasuoka N et al (1994) A case of IgA nephropathy associated with psoriasis vulgaris. Nippon Jinzo Gakkai Shi 36:779–783

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Grigorios T. Sakellariou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakellariou, G.T., Vounotrypidis, P. & Berberidis, C. Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy. Clin Rheumatol 26, 1132–1133 (2007). https://doi.org/10.1007/s10067-006-0422-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0422-z

Keywords

Navigation